How protein-based COVID vaccines could change the pandemic
Elie Dolgin • Nov 08, 2021
Jabs from Novavax and other biotech firms are coming. Scientists say they have a lot to offer.
Continue reading at Nature.
Drug trial results show that vaccines aren't the only use for the mRNA technology behind the most widely used COVID-19 jabs.
FDA panel’s green light on glaucoma wearable device offers hope in sight.